VH032-thiol-C6-NH2 is an advanced E3 Ligase Ligand-Linker Conjugate designed for PROTAC (Proteolysis Targeting Chimera) drug development. This compound features the VH032 ligand, a well-characterized small molecule binder for the VHL (von Hippel-Lindau) E3 ligase, equipped with a thiol handle and a six-carbon (C6) alkyl linker terminating with an amine group. As a versatile building block, VH032-thiol-C6-NH2 enables researchers to efficiently conjugate target-binding ligands via the thiol or amine functional groups, facilitating the creation of custom PROTACs for targeted protein degradation. With its optimized linker design, this conjugate ensures effective spatial orientation and functional versatility, supporting the development of novel small-molecule degraders targeting disease-relevant proteins. VH032-thiol-C6-NH2 is ideal for medicinal chemistry, chemical biology, and early-stage drug discovery workflows that focus on advancing the field of targeted protein degradation and PROTAC therapeutics.
Structure of 2098836-63-4
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
VH032-thiol-C6-NH2 is a specially designed E3 ligase ligand-linker conjugate widely used in the development of PROTACs (Proteolysis Targeting Chimeras). Featuring a VH032 moiety (a highly validated ligand for the Von Hippel-Lindau [VHL] E3 ligase) tethered via a flexible hexyl (C6) linker and terminating in a thiol and amine group, this compound enables precise and versatile conjugation chemistry. Its unique functional groups provide essential reactive handles for further PROTAC assembly, supporting the efficient targeting and removal of disease-relevant proteins.
Mechanism
VH032-thiol-C6-NH2 operates as a modular building block in PROTAC synthesis. The VH032 unit non-covalently binds to the substrate recognition domain of the VHL E3 ubiquitin ligase complex. The hexyl (C6) linker offers spatial flexibility, while the terminal thiol and amine functionalities allow for selective coupling to various warheads or target-binding ligands via amide or thioether linkages. Upon successful conjugation, the resulting PROTAC molecule mediates target protein ubiquitination by recruiting the E3 ligase into close proximity with the protein of interest, marking it for subsequent proteasomal degradation.
Applications
VH032-thiol-C6-NH2 is extensively utilized in targeted protein degradation research and PROTAC platform development. Its customizable linker system facilitates the rapid synthesis of diverse PROTACs for high-throughput screening, medicinal chemistry optimization, and in vitro/in vivo functional studies. Typical applications include designing PROTAC tool compounds for oncology, neurodegenerative diseases, immunology, and other therapeutic indications where protein degradation offers a unique intervention strategy. Additionally, its reactive handles support site-specific conjugation and enable seamless integration into bifunctional chimeric molecules for drug discovery and development.
The E3 Ligase Ligand-Linker Conjugate, VH032-thiol-C6-NH2, plays a crucial role in the development of PROTACs by facilitating targeted protein degradation through its well-designed structure. The following provides a detailed description of this molecule, highlighting its linker, ligand, and reactive site characteristics, along with the recommended target protein ligand.
Linker: This molecule features a C6 alkyl linker, which provides moderate flexibility and length, allowing for optimal spatial orientation between the ligand and the target protein. The linker is non-cleavable, ensuring stability and sustained interaction in the cellular environment.
Ligand: The ligand component, VH032, is a potent E3 ligase recruiter characterized by its heterocyclic structure. It efficiently binds to the von Hippel-Lindau (VHL) E3 ligase, facilitating the ubiquitination process necessary for proteasome-mediated degradation of the target protein.
Reactive Site: The thiol group in this molecule serves as the reactive site, which couples with the target protein ligand through thiol-reactive chemistry. Recommended reaction types include disulfide bond formation or Michael addition, providing robust and specific conjugation.
Recommended Target Protein Ligand: A compatible warhead for this molecule is an electrophilic moiety, such as an acrylamide, which can form a covalent bond with the thiol group. This combination enhances the selectivity and potency of the PROTAC, making it suitable for applications in studying protein functions and validating therapeutic targets in a research setting.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.